ALSO READZydus receives final approval for Dexmedetomidine Hydrochloride Injection Zydus Cadila gets USFDA nod for Tizanidine tablets Cadila Healthcare Ltd rose for a fifth straight session today Zydus Cadila gets final approval for Metoprolol Succinate Extended Release Tablets Zydus receives final approval for Tizanidine Tablets USP
"The Company has divested its entire shareholding in Bremer Pharma GmbH, Germany (Bremer), Wholly Owned Subsidiary of the Company," the company informed BSE.
Consequently, Bremer ceased to be a subsidiary of the company, it added.
This was done on an enterprise value of Euro 22,63,431 on which share sale value is Euro 8,27,344.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)